Levels of Antithyroid Antiperoxidase and Antithyroglobulin Antibodies in Patients with Graves Hyperthyroidism – Predictors of Initial and Sustained Remission and Consecutive Hypothyroidism

1 Argas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH, Meza-Cabrera I. Autoimmune thyroid disease (flajani-parry-graves-von basedow disease): Etiopathogenesis, clinical manifestations and diagnosis. In: Imam S, Ahmad S, editors. Thyroid Disorders. Cham: Springer; 2016. Search in Google Scholar

2 Yanachkova V, Kamenov Z. The relationship between thyroid dysfunction during pregnancy and gestational diabetes mellitus. Endokrynol Pol. 2021;72(3):226-31. https://doi.org/10.5603/EP.a2021.0016 PMid:33619713 Search in Google Scholar

3 De Groot LJ, Larsen PR, Hennemann G. The Thyroid and its Diseases. 6^th ed. United Kingdom: Churchill Livingstone; 1995 Search in Google Scholar

4 Weetman A. Autoimmune thyroid disease. Endocrine. 2020;68(2):258-60. https://doi.org/10.1007/s12020-020-02188-6 PMid:320523689. Search in Google Scholar

5 Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. 2018 European thyroid association guideline for the management of graves’ hyperthyroidism. Eur Thyroid J. 2018;7(4):167-86. http://doi.org/10.1159/000490384 PMid:302837357. Search in Google Scholar

6 McGrogan A, Seaman HE, Wright JW, de Vries CS. The incidence of autoimmune thyroid disease: A systematic review of the literature. Clin Endocrinol (Oxf). 2008;69(5):687-96. https://doi.org/10.1111/j.1365-2265.2008.03338.x PMid:18673466 Search in Google Scholar

7 Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ, O’Leary P. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: A 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab. 2010;95(3):1095-104. http://doi.org/10.1210/jc.2009-1977 PMid:20097710 Search in Google Scholar

8 Wahab F, Kearney E, Joseph S. The presence of thyroid peroxidase antibodies in Graves’ disease is predictive of disease duration and relapse rates. Endocr Abstr. 2013;31:P367. https://doi.org/10.1530/endoabs.31.P367 Search in Google Scholar

9 Bartalena L, Piantanida E, Gallo D, Ippolito S, Tanda ML. Management of Graves’ hyperthyroidism: Present and future. Expert Rev Endocrinol Metab. 2022;17(2):153-66. http://doi.org/10.1080/17446651.2022.2052044 PMid:35287535 Search in Google Scholar

10 Vargas-Uricoechea H. Molecular mechanisms in autoimmune thyroid disease. Cells. 2023;12(6):918. http://doi.org/10.3390/cells12060918 PMid:36980259 Search in Google Scholar

11 Bossowski A, Stasiak-Barmuta A, Urban M. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves’ disease. Horm Res. 2005;64(4):189-97. https://doi.org/10.1159/000088875 PMid:16220002 Search in Google Scholar

12 De Carvalho G, Perez C, Ward L. The clinical use of thyroid function tests. Arq Bras Endocrinol Metabol 2013;57(3):193-204. https://doi.org/10.1590/S0004-27302013000300005 PMid:23681265 Search in Google Scholar

13 Fröhlich E, Wahl R. Thyroid autoimmunity: Role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 2017;8:521. http://doi.org/10.3389/fimmu.2017.00521 PMid:28536577 Search in Google Scholar

14 Kaczur V, Vereb G, Molnár I, Krajczár G, Kiss E, Farid NR, et al. Effect of anti-thyroid peroxidase (TPO) antibodies on TPO activity measured by chemiluminescence assay. Clin Chem 1997;43(8 Pt 1):1392-6. PMid:9267319 Search in Google Scholar

15 Xie LD, Gao Y, Li MR, Lu GZ, Guo XH. Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto’s thyroiditis with different thyroid functional status. Clin Exp Immunol. 2008;154(2):172-6. https://doi.org/10.1111/j.1365-2249.2008.03756.x PMid:18778360 Search in Google Scholar

16 Caturegli P, Kuppers RC, Mariotti S, Burek CL, Pinchera A, Ladenson PW, et al. IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease. Clin Exp Immunol 1994;98(3):464-9. https://doi.org/10.1111/j.1365-2249.1994.tb05514.x PMid:7994910 Search in Google Scholar

17 Siriwardhane T, Krishna K, Ranganathan V, Jayaraman V, Wang T, Bei K, et al. Significance of anti-TPO as an early predictive marker in thyroid disease. Autoimmune Dis. 2019;2019:1684074. https://doi.org/10.1155/2019/1684074 PMid:31467701 Search in Google Scholar

18 Azizi F, Amouzegar A, Tohidi M, Hedayati M, Khalili D, Cheraghi L, et al. Increased remission rates after long-term methimazole therapy in patients with Graves’ disease: Results of a randomized clinical trial. Thyroid. 2019;29(9):1192-200. https://doi.org/10.1089/thy.2019.0180 PMid:31310160 Search in Google Scholar

19 Alhubaish ES, Alibrahim NT, Mansour AA. The Clinical Implications of anti-thyroid peroxidase antibodies in Graves’ disease in basrah. Cureus. 2023;15(3):e36778. https://doi.org/10.7759/cureus.36778 PMid:37123800 Search in Google Scholar